blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1036821

EP1036821 - Process for the preparation of thiazine-indigo compounds and of new intermediates therefor [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.12.2004
Database last updated on 03.10.2024
Most recent event   Tooltip14.12.2007Lapse of the patent in a contracting state
New state(s): PT
published on 16.01.2008  [2008/03]
Applicant(s)For all designated states
Clariant Finance (BVI) Limited
Citco Building, Wickhams Cay, P.O. Box 662
Road Town, Tortola / VG
[2000/38]
Inventor(s)01 / Borchert, Till
3, Croisée des Lys
68300 Saint Louis / FR
02 / Kaul, Bansi Lal
Bruckackerstrasse 48
4105 Biel-Benken / CH
03 / Piastra, Bruno
12, Rue Lavoisier
68330 Huningue / FR
04 / Wolf, Valérie
15A, Rue du Général de Gaulle
68990 Galfingue / FR
05 / Rothe, Petra
Frankfurter-Strasse 69
65779 Kelkheim / DE
06 / Unverdorben, Leonhard
Johann-Peter-Bach-Strasse 3
61130 Nidderau / DE
[2000/38]
Representative(s)D'haemer, Jan Constant, et al
Clariant International Ltd.
Industrial Property Department
Rothausstrasse 61
4132 Muttenz / CH
[N/P]
Former [2000/38]D'haemer, Jan Constant, et al
Clariant International Ltd., Industrial Property Department, Rothausstrasse 61
4132 Muttenz / CH
Application number, filing date00810221.216.03.2000
[2000/38]
Priority number, dateGB1999000612018.03.1999         Original published format: GB 9906120
GB1999001880511.08.1999         Original published format: GB 9918805
[2000/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1036821
Date:20.09.2000
Language:EN
[2000/38]
Type: B1 Patent specification 
No.:EP1036821
Date:28.01.2004
Language:EN
[2004/05]
Search report(s)(Supplementary) European search report - dispatched on:EP04.07.2000
ClassificationIPC:C09B7/00, C07D513/04, C07C323/62, C07C323/63, C07D279/16, C08K5/46, C09D5/00, C09D11/00, // (C07D513/04, 279:00, 235:00)
[2000/38]
CPC:
C09D11/32 (EP,US); C07D279/00 (KR); A61K8/49 (EP,US);
A61Q1/02 (EP,US); C07C323/62 (EP,US); C07C323/63 (EP,US);
C07D279/16 (EP,US); C09B7/00 (EP,US); C09D5/035 (EP,US);
G03G9/0912 (EP,US); G03G9/0914 (EP,US); A61K2800/43 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/38]
TitleGerman:Verfahren zur Herstellung von Thiazin-Indigoverbindungen und von neuen Zwischenprodukten dafür[2000/38]
English:Process for the preparation of thiazine-indigo compounds and of new intermediates therefor[2000/38]
French:Procédé pour la préparation de composés thiazine-indigo et de nouveaux intermédiaires pour ceux-ci[2000/38]
Examination procedure13.12.2000Examination requested  [2001/06]
14.11.2001Despatch of a communication from the examining division (Time limit: M06)
30.03.2002Reply to a communication from the examining division
26.11.2002Despatch of a communication from the examining division (Time limit: M04)
19.03.2003Reply to a communication from the examining division
28.05.2003Communication of intention to grant the patent
07.10.2003Fee for grant paid
07.10.2003Fee for publishing/printing paid
Opposition(s)29.10.2004No opposition filed within time limit [2005/03]
Fees paidRenewal fee
02.04.2002Renewal fee patent year 03
31.03.2003Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT28.01.2004
BE28.01.2004
CY28.01.2004
FI28.01.2004
IT28.01.2004
NL28.01.2004
IE16.03.2004
LU16.03.2004
MC31.03.2004
DK28.04.2004
GR28.04.2004
SE28.04.2004
ES09.05.2004
PT28.06.2004
[2008/03]
Former [2007/35]AT28.01.2004
BE28.01.2004
CY28.01.2004
FI28.01.2004
IT28.01.2004
NL28.01.2004
IE16.03.2004
LU16.03.2004
MC31.03.2004
DK28.04.2004
GR28.04.2004
SE28.04.2004
ES09.05.2004
Former [2007/08]AT28.01.2004
BE28.01.2004
CY28.01.2004
FI28.01.2004
NL28.01.2004
IE16.03.2004
LU16.03.2004
MC31.03.2004
DK28.04.2004
GR28.04.2004
SE28.04.2004
ES09.05.2004
Former [2006/12]AT28.01.2004
BE28.01.2004
FI28.01.2004
NL28.01.2004
IE16.03.2004
LU16.03.2004
MC31.03.2004
DK28.04.2004
GR28.04.2004
SE28.04.2004
ES09.05.2004
Former [2005/24]AT28.01.2004
BE28.01.2004
FI28.01.2004
IE16.03.2004
LU16.03.2004
MC31.03.2004
DK28.04.2004
GR28.04.2004
SE28.04.2004
ES09.05.2004
Former [2005/23]AT28.01.2004
BE28.01.2004
FI28.01.2004
LU16.03.2004
MC31.03.2004
DK28.04.2004
GR28.04.2004
SE28.04.2004
ES09.05.2004
Former [2005/02]AT28.01.2004
BE28.01.2004
FI28.01.2004
MC31.03.2004
DK28.04.2004
GR28.04.2004
SE28.04.2004
ES09.05.2004
Former [2005/01]AT28.01.2004
BE28.01.2004
FI28.01.2004
GR28.04.2004
SE28.04.2004
ES09.05.2004
Former [2004/46]AT28.01.2004
FI28.01.2004
GR28.04.2004
SE28.04.2004
ES09.05.2004
Former [2004/43]AT28.01.2004
FI28.01.2004
GR28.04.2004
SE28.04.2004
Former [2004/41]FI28.01.2004
GR28.04.2004
SE28.04.2004
Former [2004/40]FI28.01.2004
SE28.04.2004
Documents cited:Search[XA]US3803139  (KAUL B) [X] 21,22 * column 3, line 49 - line 60; example - * [A] 1-20;
 [AD]DE2536120  (BASF AG) [AD] 1-22 * example -; claim - *;
 [XA]WO9832800  (CLARIANT FINANCE BVI LTD [CH], et al) [X] 21,22 * page 32, paragraph 4 - page 33, paragraph L; claims 1,7-10 * * page 10, paragraph 3 - page 11, paragraph 1 * [A] 1-20;
 [AD]  - B.L.KAUL, "studies on heterocyclic colouring matters...", HELVETICA CHIMICA ACTA., VERLAG HELVETICA CHIMICA ACTA. BASEL., CH, (1974), vol. 57, no. 8, ISSN 0018-019X, pages 2664 - 78, XP002140383 [AD] 1-22 * page 2667, scheme 5 *; page 2675, paragraph L - page 2676, paragraph 2 *

DOI:   http://dx.doi.org/10.1002/hlca.19740570846
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.